VPC-23019

Size	Price	Stock	Quantity
Get Quotation Now Add to Cart Bulk Inquiry

Shipping and handling fee USD40, Free delivery is qualified when the total value of your order exceeds USD500.If the item is temporarily out of stock. Please email to order@pharm-intermediates.com,we will inform you when we have it in stock.

Chemical Information

Product name：VPC-23019	Purity：98% min
CAS NO：449173-19-7	Solubility：DMSO : 125 mg/mL (335.66 mM)
Molecular Formula：C₁₇H₂₉N₂O₅P	Package：Package according to customer requirements
Molecular Weight：372.396	Storage：-20℃

Quality control

Remarks

VPC-23019 is a sphingosine-1-phosphate receptor antagonist. VPC-23019 acts as a competitive antagonist at both S1P1 and S1P3 receptors (pKis = 7.86 and 5.93, respectively). VPC-23019 can inhibit S1P-induced migration of thyroid cancer cells, ovarian cancer cells, and neural stem cells.

LPL Receptor Related Products:

Ki16425; Ki16198; AM095; Fingolimod hydrochloride; Siponimod; Ozanimod; CYM5520; JTE-013; Ponesimod; Etrasimod; AM966; CYM50308; NIBR-0213; ONO-7300243

References

[1]. Arthur C.M. Mulders, Mariëlle C. Hendriks-Balk, Marie-Jeanne Mathy, et al. Sphingosine Kinase-dependent Activation of Endothelial Nitric Oxide Synthase by Angiotensin II. Arterioscler Thromb Vasc Biol., 2006, 26:2043-2048.
[2]. Isao Inoki, Noriko Takuwa, Naotoshi Sugimoto, et al. Negative regulation of endothelial morphogenesis and angiogenesis by S1P2 receptor. Biochemical and Biophysical Research Communications, 2006, 346: 293-300.